MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Magnetic resonance-guided focused ultrasounds (MRgFUS) thalamotomy for disabling tremor secondary to multiple sclerosis.

A. Menéndez, L. Ispierto, M. Tardaguila, J. Muñoz, C. Ramo-Tello, A. González, R. Alvarez, D. Vilas (Badalona, Spain)

Meeting: 2024 International Congress

Abstract Number: 1547

Keywords: Multiple sclerosis(MS), Tremors: Clinical features, Tremors: Treatment

Category: Tremor

Objective: To describe two patients with disabling tremor secondary to multiple sclerosis (MS) treated with magnetic resonance-guided focused ultrasounds (MRgFUS) thalamotomy.

Background: MRgFUS thalamotomy improves refractory tremor in essential tremor and Parkinson’s disease.  Tremor associated to other neurological conditions could also benefit from this technique.

Method: A right-handed 52-year-old woman was diagnosed with relapsing-remitting MS (RRMS) at 36-years-old, being currently in a secondary progressive form (Expanded Disability Status Scale (EDSS) of 8.0.) At the age of 38, bilateral action tremor appeared, being disabling for daily living activities. The Fahn-Tolosa-Marin (FTM) total score was 82 (part A: 21, B: 35, and C: 26). The second patient was a right-handed 34-year-old man diagnosed with RRMS at the age of 25 (EDSS 6.0). A progressive and disabling upper extremities action tremor started 6 years after disease onset. The FTM total score was 88 (part A : 28, B: 36, and C: 24). In both cases tremor was refractory to drugs, and were assessed in a multidisciplinary meeting, and were selected for out of label use of MRgFUS.

Results: Both patients underwent MRgFUS left thalamotomy. Stereotactic planning was performed for the left VIM and tractography was used to localize the adjacent anatomical structures. A significant improvement of the tremor was observed in both patients, remaining stable at 3 months (Patient 1: FTM-treated side: baseline: 28, post-procedure: 12, 3-months: 12; Patient 2: baseline: 28, post-procedure: 18, 3-months: 18). Patient 1 reported a patient-global impression of improvement (PGI-I) of  “much better”. Patient 2 reported a subjective improvement of 40%, being able to perform daily activities such as eating alone, carrying a mobile phone or help with transfers.  As side effects, transient worsening of basal dysarthria and right upper limb dysmetria, as well as transient paresthesia in the tongue were observed.

Conclusion: MRgFUS thalamotomy was a safe and effective treatment for disabling refractory tremor associated to MS in our two cases. Although the improvement of the tremor was partial, its impact in the quality of life of patients is significant. However, more studies are needed to assess definite criteria, and patients should be selected based on MS clinical picture.

To cite this abstract in AMA style:

A. Menéndez, L. Ispierto, M. Tardaguila, J. Muñoz, C. Ramo-Tello, A. González, R. Alvarez, D. Vilas. Magnetic resonance-guided focused ultrasounds (MRgFUS) thalamotomy for disabling tremor secondary to multiple sclerosis. [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/magnetic-resonance-guided-focused-ultrasounds-mrgfus-thalamotomy-for-disabling-tremor-secondary-to-multiple-sclerosis/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/magnetic-resonance-guided-focused-ultrasounds-mrgfus-thalamotomy-for-disabling-tremor-secondary-to-multiple-sclerosis/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley